Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0423 per EA under NDC 59651039205. Its NADAC has been published 253 times since Aug 25, 2021.
Strength
15 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651039205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 253 times since Aug 25, 2021, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0560 (Apr 13, 2022) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0481 |
| Average price | $0.0480 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 253 |
| Tracking since | Aug 25, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0423 per EA (NDC 59651039205), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 22.7%. It has been tracked across 253 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Aug 25, 2021, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0560 (Apr 13, 2022), with a median of $0.0481 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUSPIRONE HCL 15 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 59651039205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification